HugoAkabaneMD

Internal Medicine • Portland, OR

Hematology/Oncology

Program Director Leukemia & Bone Marrow Transplant

Join to view full profile

Dr. Akabane is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Akabane's full profile

Already have an account?

Office
4805 NE Glisan St
Ste 11N
Portland, OR 97213
Phone+1 503-215-1350

Education & Training

University of California (San Francisco)/FresnoFellowship, Hematology and Medical Oncology, 2017 - 2020
MetroWest Medical CenterResidency, Internal Medicine, 2017
Paulista School of MedicineClass of 2002

Certifications & Licensure

OH State Medical License 2023 - 2025
OR State Medical License 2023 - 2025
LA State Medical License 2020 - 2024
CA State Medical License 2017 - 2022
MA State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

12 citations
Clinical Significance and Management of MRD in Adults With Acute Lymphoblastic Leukemia.
Hugo Akabane, Aaron C Logan
Clinical Advances in Hematology & Oncology. 2020-07-01
6 citations
The Future of Molecular Analysis in Melanoma: Diagnostics to Direct Molecularly Targeted Therapy.
Hugo Akabane, Ryan J. Sullivan
American Journal of Clinical Dermatology. 2016-02-01
De novo monocytic-M5b AML with t(8;16) (p11.2; p13.3) KAT6A/CREBBP fusion and FLT3-TKD mutation complicated by chemotherapy-induced Takotsubo cardiomyopathy.
Anil Ananthaneni, Taras Benzar, Nazar Hafiz, Hugo Akabane
BMJ Case Reports. 2023-03-28